FTC Says Cephalon Bought Off Would-Be Competitors
By Ben James ( February 14, 2008, 12:00 AM EST) -- The U.S. Federal Trade Commission has filed a lawsuit against Cephalon Inc. that alleges the pharmaceutical company paid off four would-be generics competitors to keep them out of the $800 million annual U.S. market for Cephalon's narcolepsy drug Provigil until 2012....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.